Five days of ceftriaxone was sufficient to increase GLT-1 expression in WT and R6/2 mice at 13 weeks of age, although later ages were not tested due to the reduced lifespan of the R6/2 mouse model of HD (Sari et al., 2010). The gene discussed is SLC1A2; the disease is Huntington disease.